アステラス製薬の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2025/02/21 | 1,458.5 | 1,474 | 1,458.5 | 1,465.5 | +12 | +0.8% | 3,289,500 |
2025/02/20 | 1,455 | 1,467.5 | 1,444 | 1,453.5 | -9.5 | -0.6% | 5,126,100 |
2025/02/19 | 1,467.5 | 1,472.5 | 1,456.5 | 1,463 | -13 | -0.9% | 4,649,800 |
2025/02/18 | 1,476 | 1,486.5 | 1,473 | 1,476 | -1 | -0.1% | 3,024,700 |
2025/02/17 | 1,481 | 1,489.5 | 1,476 | 1,477 | -11.5 | -0.8% | 3,607,900 |
2025/02/14 | 1,502.5 | 1,517.5 | 1,477 | 1,488.5 | -5.5 | -0.4% | 9,077,600 |
2025/02/13 | 1,478.5 | 1,510 | 1,474.5 | 1,494 | +45.5 | +3.1% | 8,845,200 |
2025/02/12 | 1,447.5 | 1,512 | 1,418.5 | 1,448.5 | -4.5 | -0.3% | 20,083,500 |
2025/02/10 | 1,440 | 1,462 | 1,428.5 | 1,453 | +19.5 | +1.4% | 6,959,000 |
2025/02/07 | 1,427 | 1,444 | 1,422.5 | 1,433.5 | +0.5 | ±0% | 4,386,300 |
2025/02/06 | 1,431.5 | 1,445 | 1,426 | 1,433 | +5.5 | +0.4% | 5,584,000 |
2025/02/05 | 1,470.5 | 1,472.5 | 1,415 | 1,427.5 | -57.5 | -3.9% | 12,620,400 |
2025/02/04 | 1,482 | 1,503.5 | 1,479 | 1,485 | +13.5 | +0.9% | 5,221,900 |
2025/02/03 | 1,500 | 1,503.5 | 1,471 | 1,471.5 | -43 | -2.8% | 7,698,800 |
2025/01/31 | 1,529 | 1,529.5 | 1,513 | 1,514.5 | -14.5 | -0.9% | 5,353,700 |
2025/01/30 | 1,531.5 | 1,535 | 1,519 | 1,529 | -2.5 | -0.2% | 3,348,500 |
2025/01/29 | 1,535 | 1,537 | 1,519.5 | 1,531.5 | -7 | -0.5% | 5,297,700 |
2025/01/28 | 1,532.5 | 1,553 | 1,527 | 1,538.5 | +20 | +1.3% | 5,634,600 |
2025/01/27 | 1,508.5 | 1,527.5 | 1,507 | 1,518.5 | +16.5 | +1.1% | 6,081,200 |
2025/01/24 | 1,500 | 1,514.5 | 1,492.5 | 1,502 | +24 | +1.6% | 4,080,600 |
2025/01/23 | 1,477 | 1,482 | 1,460.5 | 1,478 | -8 | -0.5% | 4,945,100 |
2025/01/22 | 1,492.5 | 1,497.5 | 1,484 | 1,486 | -2 | -0.1% | 4,282,300 |
2025/01/21 | 1,489.5 | 1,498 | 1,484 | 1,488 | +2.5 | +0.2% | 2,979,000 |
2025/01/20 | 1,494 | 1,496.5 | 1,476 | 1,485.5 | -8.5 | -0.6% | 5,536,000 |
2025/01/17 | 1,504 | 1,507 | 1,490 | 1,494 | -10.5 | -0.7% | 5,580,800 |
2025/01/16 | 1,525 | 1,526 | 1,504.5 | 1,504.5 | -24 | -1.6% | 4,719,800 |
2025/01/15 | 1,539 | 1,559.5 | 1,528.5 | 1,528.5 | +12 | +0.8% | 7,174,400 |
2025/01/14 | 1,513.5 | 1,523 | 1,502 | 1,516.5 | +6.5 | +0.4% | 8,152,200 |
2025/01/10 | 1,530 | 1,535.5 | 1,507 | 1,510 | -26 | -1.7% | 8,082,200 |
2025/01/09 | 1,522 | 1,544.5 | 1,513.5 | 1,536 | +15 | +1% | 6,352,500 |
2025/01/08 | 1,532 | 1,540.5 | 1,521 | 1,521 | -16 | -1% | 4,685,800 |
2025/01/07 | 1,534.5 | 1,544 | 1,528 | 1,537 | +10 | +0.7% | 4,581,500 |
2025/01/06 | 1,535 | 1,536.5 | 1,516.5 | 1,527 | -7.5 | -0.5% | 7,168,100 |
2024/12/30 | 1,548.5 | 1,551 | 1,533 | 1,534.5 | -10 | -0.6% | 5,159,600 |
2024/12/27 | 1,530 | 1,550 | 1,530 | 1,544.5 | +15 | +1% | 5,433,500 |
2024/12/26 | 1,517 | 1,529.5 | 1,517 | 1,529.5 | +8.5 | +0.6% | 4,790,900 |
2024/12/25 | 1,539.5 | 1,541 | 1,513.5 | 1,521 | -9.5 | -0.6% | 4,191,500 |
2024/12/24 | 1,524.5 | 1,535 | 1,516 | 1,530.5 | +11.5 | +0.8% | 3,981,100 |
2024/12/23 | 1,530 | 1,534 | 1,507.5 | 1,519 | -23.5 | -1.5% | 5,027,300 |
2024/12/20 | 1,528 | 1,544.5 | 1,525.5 | 1,542.5 | +22.5 | +1.5% | 9,307,400 |
2024/12/19 | 1,507 | 1,526 | 1,501.5 | 1,520 | +10.5 | +0.7% | 4,881,400 |
2024/12/18 | 1,510 | 1,517 | 1,504.5 | 1,509.5 | -7 | -0.5% | 5,961,800 |
2024/12/17 | 1,517 | 1,523.5 | 1,507 | 1,516.5 | -10.5 | -0.7% | 7,153,400 |
2024/12/16 | 1,552.5 | 1,556 | 1,522 | 1,527 | -29.5 | -1.9% | 5,263,800 |
2024/12/13 | 1,553 | 1,570 | 1,547 | 1,556.5 | -25 | -1.6% | 7,713,400 |
2024/12/12 | 1,576 | 1,589 | 1,573.5 | 1,581.5 | +7 | +0.4% | 4,357,900 |
2024/12/11 | 1,577.5 | 1,592.5 | 1,570.5 | 1,574.5 | -6 | -0.4% | 4,426,400 |
2024/12/10 | 1,598.5 | 1,599.5 | 1,575 | 1,580.5 | -2 | -0.1% | 3,738,500 |
2024/12/09 | 1,581 | 1,592.5 | 1,575.5 | 1,582.5 | +1.5 | +0.1% | 3,362,900 |
2024/12/06 | 1,591 | 1,596 | 1,576 | 1,581 | -12 | -0.8% | 3,658,200 |
51~
100
件表示中 / 3695件
類似銘柄と比較する
現在ご覧いただいている「アステラス薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
アステラス薬 | 139,600円 | +0.9% | +380.2% | 5.59% | 19.23倍 | 1.65倍 |
|
医薬品国内2位。開発技術起点の研究開発体制。前立腺がん薬が柱。遺伝子・細胞治療技術育成 |
武 田 | 423,400円 | -1.1% | +75.3% | 4.72% | 29.00倍 | 0.95倍 |
|
国内製薬首位。がん、中枢神経、消化器、希少疾患等に重点。巨額買収で世界売上上位10強入り |
大塚HD | 707,500円 | +2.2% | +10.2% | 1.70% | 13.59倍 | 1.37倍 |
|
国内製薬大手で抗精神病薬が主力。ポカリスエットなど機能性食品も拡大。世界90カ所に工場 |
塩野義 | 240,500円 | +5.7% | +3.9% | 2.55% | 11.97倍 | 1.58倍 |
|
抗HIV薬が大型製品に。感染症、疼痛・中枢神経領域に強み。米国に積極展開。欧州、アジア開拓 |
エーザイ | 405,000円 | +1.7% | -2.9% | 3.95% | 26.57倍 | 1.39倍 |
|
神経系、がん領域に強み。認知症薬は米バイオジェンと、抗がん薬では米メルクと国際協業推進 |
市場注目の銘柄
チャート関連のコラム